Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · STAAR Surgical (STAA)

STAAR Surgical raises interim co-CEO Deborah Andrews' salary to $575,000

Neutral Impact 2 of 5 leadership Written later

STAAR Surgical's Compensation Committee approved a base salary increase for Deborah Andrews, its Interim Co-Chief Executive Officer and Chief Financial Officer, from $512,000 to $575,000, effective June 8, 2026. The committee also raised her target annual cash bonus from 55% to 60% of base salary, citing a review of competitive market pay data and her contributions to strategic and operational objectives.

Key points

  • Base salary rises from $512,000 to $575,000, effective June 8, 2026
  • Target annual cash bonus increases from 55% to 60% of base salary
  • Committee cited competitive market compensation data and Ms. Andrews' contributions to company objectives

The filing

CompanySTAAR Surgical (STAA)
Form8-K, current report
Filed with the SECJun 9, 2026, 4:02 PM ET
Accession number0000718937-26-000027

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 09, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.